Reaction Details |
| Report a problem with these data |
Target | Vasoactive intestinal polypeptide receptor 2 |
---|
Ligand | BDBM50360601 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_854483 (CHEMBL2160805) |
---|
IC50 | 12800±n/a nM |
---|
Citation | Xiong, Y; Guo, J; Candelore, MR; Liang, R; Miller, C; Dallas-Yang, Q; Jiang, G; McCann, PE; Qureshi, SA; Tong, X; Xu, SS; Shang, J; Vincent, SH; Tota, LM; Wright, MJ; Yang, X; Zhang, BB; Tata, JR; Parmee, ER Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-ß-alanine (MK-0893) for the treatment of type II diabetes. J Med Chem55:6137-48 (2012) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Vasoactive intestinal polypeptide receptor 2 |
---|
Name: | Vasoactive intestinal polypeptide receptor 2 |
Synonyms: | VIP 2 | VIP2R | VIPR2 | VIPR2_HUMAN |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 49488.30 |
Organism: | Homo sapiens (Human) |
Description: | VIP 2 VIPR2 HUMAN::P41587 |
Residue: | 438 |
Sequence: | MRTLLPPALLTCWLLAPVNSIHPECRFHLEIQEEETKCAELLRSQTEKHKACSGVWDNIT
CWRPANVGETVTVPCPKVFSNFYSKAGNISKNCTSDGWSETFPDFVDACGYSDPEDESKI
TFYILVKAIYTLGYSVSLMSLATGSIILCLFRKLHCTRNYIHLNLFLSFILRAISVLVKD
DVLYSSSGTLHCPDQPSSWVGCKLSLVFLQYCIMANFFWLLVEGLYLHTLLVAMLPPRRC
FLAYLLIGWGLPTVCIGAWTAARLYLEDTGCWDTNDHSVPWWVIRIPILISIIVNFVLFI
SIIRILLQKLTSPDVGGNDQSQYKRLAKSTLLLIPLFGVHYMVFAVFPISISSKYQILFE
LCLGSFQGLVVAVLYCFLNSEVQCELKRKWRSRCPTPSASRDYRVCGSSFSRNGSEGALQ
FHRGSRAQSFLQTETSVI
|
|
|
BDBM50360601 |
---|
n/a |
---|
Name | BDBM50360601 |
Synonyms: | CHEMBL1933349 | MK-0893 |
Type | Small organic molecule |
Emp. Form. | C32H27Cl2N3O4 |
Mol. Mass. | 588.48 |
SMILES | COc1ccc2cc(ccc2c1)-c1cc(nn1[C@@H](C)c1ccc(cc1)C(=O)NCCC(O)=O)-c1cc(Cl)cc(Cl)c1 |r| |
Structure |
|